Optimal management of bleeding complications after cardiac surgery

N. J. Skubas, G. J. Despotis

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) are at increased risk for excessive perioperative blood loss requiring transfusion of blood products. Point-of-care evaluation of platelets, coagulation factors, and fibrinogen can enable physicians to assess bleeding abnormalities rapidly. They also can facilitate the optimal administration of pharmacologic and transfusion-based therapy and allow physicians to identify patients with surgical bleeding. The ability to reduce the unnecessary use of blood products in this setting has important implications for emerging issues in blood inventory and blood costs. The ability to decrease operative time along with re-exploration rates has important consequences for health care costs in an increasingly managed health care environment.

Original languageEnglish
Pages (from-to)217-228
Number of pages12
JournalSeminars in Cardiothoracic and Vascular Anesthesia
Issue number3
StatePublished - Jan 1 2001


Dive into the research topics of 'Optimal management of bleeding complications after cardiac surgery'. Together they form a unique fingerprint.

Cite this